Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol

Introduction Approximately 5%–10% of new rectal cancers are locally advanced (locally advanced rectal cancer (LARC)) at presentation with 4%–8% recurring (locally recurrent rectal cancer (LRRC)) after initial treatment. Patients with potentially curable disease have to consider many trade-offs when...

Full description

Saved in:
Bibliographic Details
Main Authors: Martyn Evans, Hayley Anne Hutchings, Dean Anthony Harris, Deena Harji, Anwen Williams
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e056984.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583700050608128
author Martyn Evans
Hayley Anne Hutchings
Dean Anthony Harris
Deena Harji
Anwen Williams
author_facet Martyn Evans
Hayley Anne Hutchings
Dean Anthony Harris
Deena Harji
Anwen Williams
author_sort Martyn Evans
collection DOAJ
description Introduction Approximately 5%–10% of new rectal cancers are locally advanced (locally advanced rectal cancer (LARC)) at presentation with 4%–8% recurring (locally recurrent rectal cancer (LRRC)) after initial treatment. Patients with potentially curable disease have to consider many trade-offs when considering major exenterative surgery. There are no decision tools for these patients and current resources have found to not meet minimum international standards. The overall aim of this study is to produce a validated patient decision aid (PtDA) to assist patients considering radical pelvic exenteration for LARC and LRRC created in line with international minimum standards.Methods and analysis This study is a national, multicentre mixed methods project and has been designed in keeping with guidance from the International Patient Decision Aids Standard.This study is in four stages. In stage 1, we will develop the PtDA and its content using agile developmental methodology. In stage 2, we will assess the content and face validity of the PtDA using mixed-methods with key stakeholders. In stage 3, we will assess the feasibility and efficacy of the PtDA. In stage 4, we will establish the barriers and facilitators to the use of a PtDA in the outpatient setting. Questionnaires including the QQ-10, EORTC PATSAT-C33, Preparation for Decision-Making Scale and the NoMAD survey will be analysed during the study. Interviews will be analysed using thematic analysis.Ethics and dissemination Research ethics approval from North of Scotland Research Ethics Service 19/NS/0056 (IRAS 257890) has been granted. Results will be published in open access peer-reviewed journals, presented in conferences and distributed through bowel research UK charity. External endorsement will be sought from the International Patient Decision Standards Collaboration inventory of PtDAs.PROSPERO registration number CRD42019122933.
format Article
id doaj-art-1d02422276c14f38854c69a035890fa0
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-1d02422276c14f38854c69a035890fa02025-01-28T08:20:11ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-056984Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocolMartyn Evans0Hayley Anne Hutchings1Dean Anthony Harris2Deena Harji3Anwen Williams4Department of Colorectal Surgery, Swansea University Health Board, Swansea, UKSchool of Medicine, Swansea University, Swansea, UKDepartment of Colorectal Surgery, Swansea University Health Board, Swansea, UKDepartment of Surgery, Manchester University Foundation Trust, Northern Surgical Trainees Research Association, Newcastle, UKDepartment of Colorectal Surgery, Swansea University Health Board, Swansea, UKIntroduction Approximately 5%–10% of new rectal cancers are locally advanced (locally advanced rectal cancer (LARC)) at presentation with 4%–8% recurring (locally recurrent rectal cancer (LRRC)) after initial treatment. Patients with potentially curable disease have to consider many trade-offs when considering major exenterative surgery. There are no decision tools for these patients and current resources have found to not meet minimum international standards. The overall aim of this study is to produce a validated patient decision aid (PtDA) to assist patients considering radical pelvic exenteration for LARC and LRRC created in line with international minimum standards.Methods and analysis This study is a national, multicentre mixed methods project and has been designed in keeping with guidance from the International Patient Decision Aids Standard.This study is in four stages. In stage 1, we will develop the PtDA and its content using agile developmental methodology. In stage 2, we will assess the content and face validity of the PtDA using mixed-methods with key stakeholders. In stage 3, we will assess the feasibility and efficacy of the PtDA. In stage 4, we will establish the barriers and facilitators to the use of a PtDA in the outpatient setting. Questionnaires including the QQ-10, EORTC PATSAT-C33, Preparation for Decision-Making Scale and the NoMAD survey will be analysed during the study. Interviews will be analysed using thematic analysis.Ethics and dissemination Research ethics approval from North of Scotland Research Ethics Service 19/NS/0056 (IRAS 257890) has been granted. Results will be published in open access peer-reviewed journals, presented in conferences and distributed through bowel research UK charity. External endorsement will be sought from the International Patient Decision Standards Collaboration inventory of PtDAs.PROSPERO registration number CRD42019122933.https://bmjopen.bmj.com/content/12/6/e056984.full
spellingShingle Martyn Evans
Hayley Anne Hutchings
Dean Anthony Harris
Deena Harji
Anwen Williams
Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol
BMJ Open
title Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol
title_full Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol
title_fullStr Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol
title_full_unstemmed Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol
title_short Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol
title_sort designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer a national multicentre mixed methods study protocol
url https://bmjopen.bmj.com/content/12/6/e056984.full
work_keys_str_mv AT martynevans designingandevaluatingapatientdecisionaidforpatientswithlocallyadvancedorlocallyrecurrentrectalcanceranationalmulticentremixedmethodsstudyprotocol
AT hayleyannehutchings designingandevaluatingapatientdecisionaidforpatientswithlocallyadvancedorlocallyrecurrentrectalcanceranationalmulticentremixedmethodsstudyprotocol
AT deananthonyharris designingandevaluatingapatientdecisionaidforpatientswithlocallyadvancedorlocallyrecurrentrectalcanceranationalmulticentremixedmethodsstudyprotocol
AT deenaharji designingandevaluatingapatientdecisionaidforpatientswithlocallyadvancedorlocallyrecurrentrectalcanceranationalmulticentremixedmethodsstudyprotocol
AT anwenwilliams designingandevaluatingapatientdecisionaidforpatientswithlocallyadvancedorlocallyrecurrentrectalcanceranationalmulticentremixedmethodsstudyprotocol